Privatlivspræferencer
Inderes bruger cookies for at give en bedre brugeroplevelse og en personlig service. Ved at give samtykke til brugen af cookies kan vi udvikle en endnu bedre service og vil kunne levere indhold, der er interessant for dig.
  • Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • ShortsalgSe hvilke børsnoterede selskaber der har offentliggjorte korte positioner
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Interim Report January 1 – September 30, 2026

ALIF BSelskabsmeddelelse21.10.2026, 07.45
Download udgivelse

The positive development in the companies continues, and the pace of acquisitions is increasing
“The positive development across AddLife’s companies continues, with stronger margins, solid growth and improved cash flow. The operational improvements and strengthened balance sheet have enabled increased acquisition activity, something we have been preparing for a long time.”
Fredrik Dalborg, President and CEO

AddLife´s interim report for Q3 2026 is now available online at the company website. The interim report can be downloaded in pdf version. Visit https://reports-en.add.life/interim-report-q3-2026

THIRD QUARTER

  • Net sales increased by 7 percent to SEK 2,599 million (2,429). Adjusted for operations divested in December 2025, organic growth amounted to 4 percent and acquired growth amounted to 3 percent. 
  • Adjusted EBITA increased by 11 percent to 298 (270), corresponding to an adjusted EBITA margin of 11.5 percent (11.1). Adjusted EBITA excludes the remeasurement of contingent considerations of SEK 32 million.
  • EBITA amounted to SEK 330 million (270).
  • Profit after tax increased by 56 percent to SEK 128 million (82).
  • Earnings per share amounted to SEK 1.05 (0.66). 
  • Cash flow from operating activities increased by 62 percent to SEK 236 million (145).
  • During the quarter, the acquisition of Unicam Sistemas Analíticos Lda, Portugal, was completed. The acquisition is expected to contribute annual net sales of approximately SEK 110 million.
  • After the end of the interim period, the acquisition of Lehnen GmbH, Germany, was completed. The acquisition is expected to contribute annual net sales of approximately SEK 55 million.

JANUARY – SEPTEMBER, 2026

  • Net sales increased by 3 percent to SEK 7,965 million (7,709). Adjusted for operations divested in December 2025, organic growth amounted to 4 percent, acquired growth amounted to 2 percent.
  • Adjusted EBITA increased by 6 percent to 972 (920), corresponding to an adjusted EBITA margin of 12.2 percent (11.9). Adjusted EBITA excludes the remeasurement of contingent considerations of SEK 32 million.
  • EBITA amounted to SEK 1,004 million (920).
  • Profit after tax increased by 28 percent to SEK 386 million (302).
  • Earnings per share amounted to SEK 3.15 (2.47). For the latest 12-month period, earnings per share amounted to 5.28 (3.23). 
  • Cash flow from operating activities amounted to SEK 505 million (504).
  • The equity ratio was 44 percent (43).
  • Return on working capital (P/WC) amounted to 63 percent (62).
  • Three acquisitions were completed during and one acquisition after the interim period. The acquisitions are expected to contribute annual net sales of approximately SEK 350 million.

Stockholm, October 21, 2026

AddLife AB (publ)

For further information, please contact
Fredrik Dalborg, President and CEO, fredrik.dalborg@add.life, +46 70 516 09 01
Christina Rubenhag, CFO, christina.rubenhag@add.life, +46 70 546 72 22
www.add.life

Video conference
Investors, analysts and the media are invited to a video conference at which President and CEO Fredrik Dalborg and CFO Christina Rubenhag will present the interim report. The presentation will be given in English and take about 20 minutes after which there will be an opportunity to ask questions. The meeting will be recorded and made available online.

The video conference will be at 09:00 CEST.
If you wish to participate via video conference, please follow this link>> 

The presentation is also available on AddLife YouTube >>

About AddLife
AddLife is an independent partner in the Life Science industry that offers high-quality products, services and advice to both the private and public sectors in Europe. AddLife has 2,300 employees in about 85 operating subsidiaries each with its own brand. The Group currently has net sales of more than SEK 10 billion. AddLife shares are listed on Nasdaq Stockholm.

This information is information that AddLife is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-10-21 07:45 CEST.

Attachments
Interim Report Q3 2026